All Stories

  1. Exploring Autologous Dendritic Cells for T Cell Modulation: A Step Towards Personalized Medicine in Leishmaniasis
  2. Unleashing the immune modulatory potential of Leishmania amazonensis-derived extracellular vesicles in American cutaneous leishmaniasis
  3. Exploring structural characteristics and biological effects of the lectin from Dioclea violacea Mart. Ex Benth: an integrative review
  4. Seroprevalence and Risk Factors for Toxoplasma gondii Infection in People Living with HIV: A Cross-Sectional Study from Maputo Central Hospital, Mozambique
  5. Extracellular Vesicles Derived from Trypanosomatids: The Key to Decoding Host–Parasite Communication
  6. Unveiling the Interplay Between Dendritic Cells and Natural Killer Cells as Key Players in Leishmania Infection
  7. Natural products and their perspectives in developing new leishmanicidal molecules
  8. Detection of Leishmania infantum and Leishmania amazonensis in Bats From Endemic and Non‐endemic Areas of São Paulo State, Brazil
  9. Kupffer Cells and Hepatocytes: A Key Relation in the Context of Canine Leishmaniasis
  10. Concanavalin A, lectin from Canavalia ensiformis seeds has Leishmania infantum antipromastigote activity mediated by carbohydrate recognition domain
  11. Editorial: Neglected tropical diseases: tackling the challenges of a global world
  12. Chagas Disease: A Silent Threat for Dogs and Humans
  13. Exploiting Leishmania—Primed Dendritic Cells as Potential Immunomodulators of Canine Immune Response
  14. Insights on Host–Parasite Immunomodulation Mediated by Extracellular Vesicles of Cutaneous Leishmania shawi and Leishmania guyanensis
  15. Parasitic Infection and Immunity—A Special Biomedicines Issue
  16. Quantum Biochemistry Screening and In Vitro Evaluation of Leishmania Metalloproteinase Inhibitors
  17. A Questionnaire-Based Survey on the Long-Term Management of Canine Leishmaniosis by Veterinary Practitioners
  18. Zoonotic Visceral Leishmaniasis: New Insights on Innate Immune Response by Blood Macrophages and Liver Kupffer Cells to Leishmania infantum Parasites
  19. African Trypanosomiasis: Extracellular Vesicles Shed by Trypanosoma brucei brucei Manipulate Host Mononuclear Cells
  20. 3D-Hepatocyte Culture Applied to Parasitology: Immune Activation of Canine Hepatic Spheroids Exposed to Leishmania infantum
  21. Human toxoplasmosis in Mozambique: gaps in knowledge and research opportunities
  22. Prognostic Factors and Life Expectancy in Canine Leishmaniosis
  23. Immunophenotyping of Peripheral Blood, Lymph Node, and Bone Marrow T Lymphocytes During Canine Leishmaniosis and the Impact of Antileishmanial Chemotherapy
  24. Leishmaniosis: New Insights in a Changing World
  25. Cutaneous Leishmaniasis: The Complexity of Host’s Effective Immune Response against a Polymorphic Parasitic Disease
  26. Development of Dog Immune System: From in Uterus to Elderly
  27. Meglumine Antimoniate and Miltefosine Combined With Allopurinol Sustain Pro-inflammatory Immune Environments During Canine Leishmaniosis Treatment
  28. Canine neutrophils cooperate with macrophages in the early stages of Leishmania infantum in vitro infection
  29. Intracellular and extracellular effector activity of mouse neutrophils in response to cutaneous and visceral Leishmania parasites
  30. Dog hepatocytes are key effector cells in the liver innate immune response to Leishmania infantum
  31. Conventional Versus Natural Alternative Treatments for Leishmaniasis: A Review
  32. THREATENING THE ROOFS OVER OUR HEADS: EXPLORING THE ROLE OF ACADEMIC INSTITUTION EXPANSION IN THE GENTRIFICATION AND DISPLACEMENT OF RESIDENTS IN ECONOMICALLY DISADVANTAGED, URBAN COMMUNITIES
  33. Canine neutrophils activate effector mechanisms in response to Leishmania infantum
  34. Leishmania infantum exerts immunomodulation in canine Kupffer cells reverted by meglumine antimoniate
  35. Corrigendum to “Therapeutic effect of ursolic acid in experimental visceral leishmaniasis” [Int. J. Parasitol. Drugs Drug Resist. 7 (2017) 1–11]
  36. Therapeutic effect of ursolic acid in experimental visceral leishmaniasis
  37. A field evaluation of an isothermal DNA amplification assay for the detection of Theileria annulata infection in cattle
  38. Leishmania infantum antigens modulate memory cell subsets of liver resident T lymphocyte
  39. Population diversity of Theileria annulata in Portugal
  40. Successful treatment of feline leishmaniosis using a combination of allopurinol and N-methyl-glucamine antimoniate
  41. The Effect of Ursolic Acid on Leishmania (Leishmania) amazonensis Is Related to Programed Cell Death and Presents Therapeutic Potential in Experimental Cutaneous Leishmaniasis
  42. Hemisynthetic trifluralin analogues incorporated in liposomes for the treatment of leishmanial infections
  43. New insights into neutrophil and Leishmania infantum in vitro immune interactions
  44. Plants Used in Traditional Medicine: Extracts and Secondary Metabolites Exhibiting Antileishmanial Activity
  45. Immunization with the Leishmania infantum recombinant cyclophilin protein 1 confers partial protection to subsequent parasite infection and generates specific memory T cells
  46. Development and field trial of a Tams1-targeted isothermal DNA amplification (Tams1-lamp) assay for detection of Theileria annulata in cattle
  47. Generation of an antibody that recognizes Plasmodium chabaudi cysteine protease (chabaupain-1) in both sexual and asexual parasite life cycle and evaluation of chabaupain-1 vaccine potential
  48. Detection of Theileria and Babesia infections amongst asymptomatic cattle in Portugal
  49. Role of neutrophils in parasite persistence and in host immunity during the initial phase of Leishmania chagasi experimental infection
  50. In Vivo Antileishmanial Activity of Plant-Based Secondary Metabolites
  51. Canine leishmaniosis. Modulation of macrophage/lymphocyte interactions by L. infantum
  52. Cytokine Gene Expression in the Tissues of Dogs Infected by Leishmania infantum
  53. Analysis of the protective potential of antigens released by Leishmania (Viannia) shawi promastigotes
  54. Vaccines for the Leishmaniases: Proposals for a Research Agenda
  55. Canine leishmaniosis. Immunophenotypic profile of leukocytes in different compartments of symptomatic, asymptomatic and treated dogs
  56. Histopathology, humoral and cellular immune response in the murine model of Leishmania (Viannia) shawi
  57. Exocytosis of serine proteases and modulation of neutrophil inflammatory response in the presence of Leishmania infantum
  58. Differential expression of cytokine genes among sickle-cell-trait (HbAS) and normal (HbAA) children infected withPlasmodium falciparum
  59. Identification of regulatory T cells during experimental Leishmania infantum infection
  60. Efficacy of the liposome trifluralin in the treatment of experimental canine leishmaniosis
  61. Immunization with Leishmania infantum released proteins confers partial protection against parasite infection with a predominant Th1 specific immune response
  62. Intra-specific variability of virulence in Leishmania infantum zymodeme MON-1 strains
  63. Canine Leishmaniasis Chemotherapy: Dog's Clinical Condition and Risk of Leishmania Transmission
  64. Leishmaniasis in Portugal: enzyme polymorphism of Leishmania infantum based on the identification of 213 strains
  65. H-2 complex influences cytokine gene expression in Leishmania infantum-infected macrophages
  66. Leishmania infantum released proteins specifically regulate cytokine expression and production patterns by CD4+ and CD8+ T cells
  67. Leishmania infantum: soluble proteins released by the parasite exert differential effects on host immune response
  68. Dynamics of CD62L/CD45RB CD4+ and CD8+ lymphocyte subsets in hepatic and splenic tissues during murine visceral leishmaniasis
  69. Hepatic cellular immune responses in mice with “cure” and “non-cure” phenotype toLeishmania infantuminfection: importance of CD8+T cells and TGF-β production
  70. Experimental canine leishmaniasis: evolution of infection following re-challenge with Leishmania infantum
  71. Cytokine expression during the outcome of canine experimental infection by Leishmania infantum
  72. Cell mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniosis
  73. Infectivity of promastigotes and amastigotes of Leishmania infantum in a canine model for leishmaniosis
  74. Canine experimental infection: intradermal inoculation of Leishmania infantum promastigotes
  75. The Effect of Chloroquine on the Production of Interferon-g, Interleukin (IL)-4, IL-6, and IL-10 in Plasmodium chabaudi chabaudi in Infected C57BL6 Mice
  76. HIV/Leishmania co-infections in Portugal: diagnosis and isoenzyme characterization of Leishmania
  77. HIV/ Leishmania co-infections in Portugal: diagnosis and isoenzyme characterization of Leishmania
  78. Reliability of serological methods for detection of leishmaniasis in portuguese domestic and wild reservoirs
  79. The isolation ofLeishmania donovanimon-18, from an aids patient in Portugal: possible needle transmission
  80. HIV-Leishmania co-infection in Portugal: isolation of Leishmania infantum MON-24
  81. An experimental model for canine visceral leishmaniasis
  82. Canine Leishmaniasis: Pathological and Ecological Factors Influencing Transmission of Infection